Eversept Partners, LP ARQT ARCUTIS BIOTHERAPEUTICS INC

Ownership history in Eversept Partners, LP  ·  5 quarters on record

AI Ownership Summary

Eversept Partners, LP reported ARCUTIS BIOTHERAPEUTICS INC (ARQT) in 5 quarterly 13F filings from 2024 Q2 through 2025 Q4. Peak portfolio weight reached 0.64% in 2025 Q4. The latest visible filing shows ARQT at 0.64% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ARQT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Eversept Partners, LP's position in ARCUTIS BIOTHERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ARQT was reported at 0.64% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.64% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Eversept Partners, LP held ARQT — position size vs. price
% of Fund (quarterly)    ARQT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 434,634 +323,168 +289.9% 0.64% $12.6M 2026-02-14 (Est.) $25.86
2025 Q3 REDUCED 41.7% +51.5% 111,466 -79,692 -41.7% 0.14% $2.1M 2025-11-14 $25.00
2024 Q4 REDUCED 72.4% +12.3% 191,158 -502,105 -72.4% 0.24% $2.7M 2025-02-14 $12.78
2024 Q3 REDUCED 17.3% +52.7% 693,263 -144,584 -17.3% 0.44% $6.4M 2024-11-14 $9.93
2024 Q2 INITIATED 837,847 0.53% $7.8M 2024-08-14 $9.58

FAQ About Eversept Partners, LP and ARQT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Eversept Partners, LP reported owning ARQT?

Eversept Partners, LP reported ARQT across 5 quarterly 13F filings, from 2024 Q2 through 2025 Q4.

What was the largest reported ARQT position in Eversept Partners, LP's portfolio?

The largest reported portfolio weight for ARQT was 0.64% in 2025 Q4.

What is the latest reported ARQT position on this page?

The most recent filing on this page is 2025 Q4, when Eversept Partners, LP reported 434,634 shares, equal to 0.64% of portfolio, with an estimated market value of $12.6M.

What does the chart on this ARQT ownership page compare?

The chart compares Eversept Partners, LP's quarterly ARQT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Eversept Partners, LP time their ARQT position?

Based on 13F filing dates vs. subsequent ARQT price moves, Eversept Partners, LP correctly timed 1 out of 4 reported position changes (25%).

← Back to Eversept Partners, LP Holdings